<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>csmauldin.txt
<DESCRIPTION>CONFIRMING STATEMENT
<TEXT>
CONFIRMING STATEMENT


This Statement confirms that the undersigned has authorized and
designated the Chief Executive Officer, the Chief Financial Officer
or the Chief Operating Officer of Galectin Therapeutics Inc.
(the "Company") to execute and file on the undersigned's behalf all
Forms 3, 4 and 5 (including any amendments thereto) that the undersigned
may be required to file with the U.S. Securities and Exchange Commission
as a result of the undersigned's ownership of or transactions in securities of
the Company.  The authority of the Chief Executive Officer, the Chief
Financial Officer or the Chief Operating Officer of the Company under
this Statement shall continue until the undersigned is no longer required to
file Forms 3, 4 and 5 with regard to the undersigned's ownership of or
transactions in securities of the Company unless earlier revoked in writing.
The undersigned acknowledges that the Chief Executive Officer, the
Chief Financial Officer or the Chief Operating Officer of the Company is
not assuming any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934.



Dated as of  June 4, 2013
/s/ John F. Mauldin

Signature

John F. Mauldin


Print Name


</TEXT>
</DOCUMENT>
